Ivana Magovcevic-Liebisch headshot

Ivana Magovcevic-Liebisch, PhD, JD


Dr. Magovcevic-Liebisch has served as a member of our board of directors since August 2020 and its chairperson since January 2021. Dr. Magovcevic-Liebisch has served as the President and Chief Executive Officer and as a member of the board of directors of Vigil Neuroscience, Inc. (NASDAQ: VIGL) since July 2020. Prior to Vigil, Dr. Magovcevic-Liebisch was Executive Vice President, Chief Business Officer at Ipsen, a pharmaceutical company, from March 2018 to April 2020, where she led the External Innovation, Business Development and Alliance Management functions. Prior to Ipsen, Dr. Magovcevic-Liebisch was Executive Vice President, Chief Strategy and Corporate Development Officer at Axcella Health Inc. (NASDAQ: AXLA) from May 2017 to March 2018, and Senior Vice President, Head of Global Business Development for the specialty drug business at Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) from March 2013 to May 2017. Dr. Magovcevic-Liebisch previously worked at Dyax Corp. (acquired by Shire plc (NASDAQ: SHPG)) from April 2001 to March 2013 in management roles of increasing scope and responsibility, including Executive Vice President and Chief Operating Officer, where she launched the company’s first drug, Kalbitor® for an orphan indication, Hereditary Angiodema. Dr. Magovcevic-Liebisch began her biopharmaceutical career at Transkaryotic Therapies, Inc., where she was Director of Intellectual Property and Patent Counsel from 1998 to 2001. Dr. Magovcevic-Liebisch is currently a member of the board of directors of Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) and previously served as a member of the board of directors of Applied Genetic Technologies Corporation (NASDAQ: AGTC). She is also a trustee of the Boston Museum of Science and of the Boston Ballet, and overseer of Beth Israel Deaconess Medical Center. She received a B.A. in Biology and Chemistry from Wheaton College, a Ph.D. in Genetics from Harvard University, and a J.D. in High Technology Law from Suffolk University Law School.

Popup Close
You’re leaving the Absci website. This link is provided for your convenience, but the content is the sole responsibility of its owner. Do you want to continue?
Return to the Absci website at any time by using the “Back” button on your web browser.
Popup Image